Faron Pharmaceuticals Oy Stock Price, News & Analysis (LON:FARN)

GBX 835 0.00 (0.00 %)
(As of 01/17/2018 04:00 PM ET)
Previous CloseGBX 835
Today's RangeGBX 832.10 - GBX 840
52-Week RangeGBX 261 - GBX 875
Volume3,457 shs
Average Volume4,668 shs
Market Capitalization£244.90 million
P/E Ratio-1,897.73
Dividend YieldN/A
BetaN/A

About Faron Pharmaceuticals Oy (LON:FARN)

Faron Pharmaceuticals Oy logoFaron Pharmaceuticals Oy is a Finland-based biopharmaceutical company engaged in the biotechnology and medical research industry. The Company develops late stage clinical drugs focusing on acute organ traumas, cancer immunotherapy and vascular damage. Its product pipeline includes Traumakine (FP-1201-lyo), an Acute Respiratory Distress Syndrome (ARDS) treatment that is in phase Three development; and Clevegen (FP-1304), an anti-Clever-1 immunotheraphy tumor targeting candidate that is in pre-clinical stage development.

Receive FARN News and Ratings via Email

Sign-up to receive the latest news and ratings for FARN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Bio Therapeutic Drugs
Sub-IndustryN/A
SectorBio Therapeutic Drugs
SymbolLON:FARN
CUSIPN/A
Phone+358-2-4695151

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-1897.72727272727
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSGBX (0.44)
Net IncomeN/A
Net Margins-103,042.90%
Return on Equity-141.29%
Return on Assets-86.22%

Miscellaneous

EmployeesN/A
Outstanding Shares29,160,000

Faron Pharmaceuticals Oy (LON:FARN) Frequently Asked Questions

What is Faron Pharmaceuticals Oy's stock symbol?

Faron Pharmaceuticals Oy trades on the London Stock Exchange (LON) under the ticker symbol "FARN."

Where is Faron Pharmaceuticals Oy's stock going? Where will Faron Pharmaceuticals Oy's stock price be in 2018?

1 brokers have issued 1-year price targets for Faron Pharmaceuticals Oy's shares. Their predictions range from GBX 723 to GBX 723. On average, they expect Faron Pharmaceuticals Oy's share price to reach GBX 723 in the next year. View Analyst Ratings for Faron Pharmaceuticals Oy.

Who are some of Faron Pharmaceuticals Oy's key competitors?

Who are Faron Pharmaceuticals Oy's key executives?

Faron Pharmaceuticals Oy's management team includes the folowing people:

  • Markku Jalkanen, Chief Executive Officer, Founder, Member of the Executive Board
  • Yrjo Erik Kristian Wichmann, Chief Financial Officer, Member of the Executive Board
  • Mikael Maksimow, Vice President Operations
  • Ilse Piippo, Vice President Drug Development, Chief Medical Officer
  • Matti Karvonen, Medical Director
  • Frank Murdoch Armstrong, Non-Executive Chairman of the Board (Age 60)
  • Matti Manner, Non-Executive Vice Chairman of the Board (Age 64)
  • Juho Jalkanen, Non-Executive Director
  • Jonathan Knowles, Non-Executive Director (Age 70)
  • Huaizheng Peng, Non-Executive Director (Age 54)

How do I buy Faron Pharmaceuticals Oy stock?

Shares of Faron Pharmaceuticals Oy and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Faron Pharmaceuticals Oy's stock price today?

One share of Faron Pharmaceuticals Oy stock can currently be purchased for approximately GBX 835.

How big of a company is Faron Pharmaceuticals Oy?

Faron Pharmaceuticals Oy has a market capitalization of £244.90 million.

How can I contact Faron Pharmaceuticals Oy?

Faron Pharmaceuticals Oy's mailing address is Intelligate, Joukahaisenkatu 6, TURKU, 20520, Finland. The company can be reached via phone at +358-2-4695151.


MarketBeat Community Rating for Faron Pharmaceuticals Oy (FARN)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  91 (Vote Outperform)
Underperform Votes:  55 (Vote Underperform)
Total Votes:  146
MarketBeat's community ratings are surveys of what our community members think about Faron Pharmaceuticals Oy and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Faron Pharmaceuticals Oy (LON:FARN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 723GBX 723GBX 723GBX 663

Faron Pharmaceuticals Oy (LON:FARN) Consensus Price Target History

Price Target History for Faron Pharmaceuticals Oy (LON:FARN)

Faron Pharmaceuticals Oy (LON:FARN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
10/2/2017Panmure GordonReiterated RatingBuyView Rating Details
(Data available from 1/17/2016 forward)

Earnings

Earnings History for Faron Pharmaceuticals Oy (LON:FARN)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Faron Pharmaceuticals Oy (LON:FARN) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Faron Pharmaceuticals Oy (LON:FARN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Faron Pharmaceuticals Oy (LON FARN) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Faron Pharmaceuticals Oy (LON:FARN)

Faron Pharmaceuticals Oy (LON FARN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/11/2017Frank ArmstrongInsiderBuy1,250GBX 800£10,000
9/8/2017Jonathan KnowlesInsiderBuy63,000GBX 725£456,750
4/25/2017Jonathan KnowlesInsiderBuy1,000GBX 635£6,350
3/31/2017Jonathan KnowlesInsiderBuy19,000GBX 550£104,500
12/13/2016Jonathan KnowlesInsiderBuy7,000GBX 275£19,250
12/12/2016Jonathan KnowlesInsiderBuy10,000GBX 265£26,500
9/23/2016Leopoldo ZambelettiInsiderBuy4,000GBX 250£10,000
(Data available from 1/1/2013 forward)

Headlines

Faron Pharmaceuticals Oy (LON FARN) News Headlines

Source:
DateHeadline
Faron Pharmaceuticals Oy: Recruitment completed in Traumakine INTEREST Trial - GlobeNewswire (press release)Faron Pharmaceuticals Oy: Recruitment completed in Traumakine INTEREST Trial - GlobeNewswire (press release)
globenewswire.com - December 13 at 5:45 PM
Faron Pharmaceuticals Oy: Recruitment completed in Traumakine INTEREST TrialFaron Pharmaceuticals Oy: Recruitment completed in Traumakine INTEREST Trial
feeds.benzinga.com - December 11 at 8:03 AM
Faron Appoints Heinonen From AstraZeneca As Chief Commercial OfficerFaron Appoints Heinonen From AstraZeneca As Chief Commercial Officer
www.morningstar.co.uk - December 2 at 10:05 AM
Faron Pharmaceuticals Oy: Appointment of Chief Commercial OfficerFaron Pharmaceuticals Oy: Appointment of Chief Commercial Officer
finance.yahoo.com - December 1 at 4:36 PM
Cambrex Corp. (CBM) Appoints Gregory Brown to BoardCambrex Corp. (CBM) Appoints Gregory Brown to Board
www.streetinsider.com - November 3 at 12:28 PM
Issue of Equity & PDMR Shareholding - London South East (blog)Issue of Equity & PDMR Shareholding - London South East (blog)
www.lse.co.uk - October 13 at 4:08 PM
Frank Armstrong Buys 1,250 Shares of Faron Pharmaceuticals Oy (FARN) StockFrank Armstrong Buys 1,250 Shares of Faron Pharmaceuticals Oy (FARN) Stock
www.americanbankingnews.com - October 13 at 4:24 AM
DIRECTOR DEALINGS: Faron Pharmaceuticals Non-Exec Chair SubscribesDIRECTOR DEALINGS: Faron Pharmaceuticals Non-Exec Chair Subscribes
www.morningstar.co.uk - October 11 at 8:07 PM
BRIEF-Block Trade - Faron Pharmaceuticals says ‍proposed placing of up to 1,123,750 new ordinary sharesBRIEF-Block Trade - Faron Pharmaceuticals says ‍proposed placing of up to 1,123,750 new ordinary shares
www.reuters.com - October 5 at 11:05 PM
Faron Pharmaceuticals Oy (FARN) Insider Jonathan Knowles Buys 63,000 SharesFaron Pharmaceuticals Oy (FARN) Insider Jonathan Knowles Buys 63,000 Shares
www.americanbankingnews.com - September 11 at 1:20 PM
Faron Pharmaceuticals Oy: Interim Results for the six months ended 30 June 2017Faron Pharmaceuticals Oy: Interim Results for the six months ended 30 June 2017
finance.yahoo.com - September 6 at 6:31 PM
Faron Pharmaceuticals Oys (FARN) Buy Rating Reiterated at Panmure GordonFaron Pharmaceuticals Oy's (FARN) Buy Rating Reiterated at Panmure Gordon
www.americanbankingnews.com - September 6 at 7:20 AM
Faron Pharmaceuticals Oy: Faron announces that US FDA proposes proceeding directly to BLA submission for ... - GlobeNewswire (press release)Faron Pharmaceuticals Oy: Faron announces that US FDA proposes proceeding directly to BLA submission for ... - GlobeNewswire (press release)
globenewswire.com - September 4 at 11:06 PM
Faron Pharmaceuticals Oy: Faron announces that US FDA proposes proceeding directly to BLA submission for Traumakine® following completion of European and Japanese Phase III studiesFaron Pharmaceuticals Oy: Faron announces that US FDA proposes proceeding directly to BLA submission for Traumakine® following completion of European and Japanese Phase III studies
feeds.benzinga.com - September 4 at 7:55 AM
Faron Pharmaceuticals Oy (FARN) Receives Buy Rating from Panmure GordonFaron Pharmaceuticals Oy (FARN) Receives Buy Rating from Panmure Gordon
www.americanbankingnews.com - August 31 at 12:32 AM

SEC Filings

Faron Pharmaceuticals Oy (LON:FARN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Faron Pharmaceuticals Oy (LON FARN) Stock Chart for Wednesday, January, 17, 2018

Loading chart…

This page was last updated on 1/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.